Skip to main content
TipRanks
Go Ultimate75% OFF

Claritev (CTEV) Stock Price & Analysis

278 Followers

CTEV Stock Chart & Stats

$26.82-$0.08(-0.30%)
At close: 4:00 PM EST
$20$30$40Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$26.77 - $28.32
52-Week Range
$11.50 - $55.50
Previous Close
$26.90
Volume
N/A
Average Volume (3M)
267.86K
Market Cap
$457.95M
Enterprise Value
$5.07B
Total Cash (Recent Filing)
$10.14M
Total Debt (Recent Filing)
$4.63B
Price to Earnings (P/E)
―
Beta
2.89
Next Earnings
Mar 02, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Bookings And Diversification

Rapid bookings growth and broader demand across providers, public-sector, international, and TPA markets can reduce dependence on the core payer segment. A larger, more diversified pipeline supports recurring revenue expansion and improves the company’s ability to sustain growth over coming quarters.

Revenue Growth

Repeated year-over-year growth, a new trailing-twelve-month revenue milestone, and higher full-year guidance indicate improving commercial execution rather than a single-quarter improvement. Sustained top-line expansion should support operating leverage and provide a stronger base for future investment.

AI And Product Innovation

Combining multiple payment integrity and network capabilities into a Medicare Advantage offering can deepen customer relationships and broaden the addressable market. Production AI agents and healthcare intelligence products also create opportunities to improve workflows and strengthen differentiated data-driven services.

Bears Say

High Leverage And Negative Equity

Debt that nearly matches the asset base and negative equity leave the capital structure fragile, limiting financial flexibility during operating setbacks. High leverage can also constrain investment, increase refinancing exposure, and make it harder for improving cash flow to translate into durable shareholder value.

Persistent Net Losses

The large gap between positive operating profit and substantial net losses shows that non-operating costs or non-cash charges continue to absorb operating gains. Until bottom-line profitability improves, internal funding capacity remains limited and the company’s ability to reduce leverage is weakened.

NSA Regulatory Uncertainty

Unsettled NSA rules create uncertainty around a business area that has been an important source of claims volume and growth. Changes that affect dispute processes or economics could alter future demand, revenue visibility, and investment planning before the regulatory framework stabilizes.

Claritev News

CTEV FAQ

What was Claritev’s price range in the past 12 months?
Claritev lowest stock price was $11.50 and its highest was $55.50 in the past 12 months.
What is Claritev’s market cap?
Claritev’s market cap is $457.95M.
When is Claritev’s upcoming earnings report date?
Claritev’s next earnings report is estimated for Mar 02, 2027 (not yet confirmed), which is in 105 days.
How were Claritev’s earnings last quarter?
Claritev released its earnings results on Nov 09, 2026. The company reported -$3.64 earnings per share for the quarter, missing the consensus estimate of -$3.626 by -$0.014.
Is Claritev overvalued?
According to Wall Street analysts Claritev’s price is currently Undervalued.
Does Claritev pay dividends?
Claritev does not currently pay dividends.
What is Claritev’s EPS estimate?
Claritev’s EPS estimate is -3.19.
How many shares outstanding does Claritev have?
Claritev has 17,074,785 shares outstanding.
What happened to Claritev’s price movement after its last earnings report?
Claritev reported an EPS of -$3.64 in its last earnings report, missing expectations of -$3.626. Following the earnings report the stock price went up 5.68%.
Which hedge fund is a major shareholder of Claritev?
Hedge funds hold Claritev shares: the largest hedge-fund position in Claritev is 72,411,771 shares, and hedge funds decreased their holdings by 45.3K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology